Загрузка...
Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...
Сохранить в:
| Опубликовано в: : | J Vet Intern Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/ https://ncbi.nlm.nih.gov/pubmed/34114259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|